EasyMed Services, Inc.
OTC Bulletin Board : EMYSF

EasyMed Services, Inc.

February 09, 2012 08:48 ET

EasyMed's CEO Update

TORONTO, ONTARIO--(Marketwire - Feb. 9, 2012) - EasyMed Services, Inc. (CNSX:EZM)(OTCBB:EMYSF)(MUN:EY6) ("EasyMed" or the "Company"), a leading provider of mobile technology solutions for the healthcare industry, is pleased to announce that it has successfully completed the following milestones. The CEO Andrew Ritchie is pleased to update shareholders on the great progress that has been achieved in the following areas:

  1. Development and introduction of our new International Medical Passport software - We achieved our target of launching this software on the 1st of February 2012. We have signed a joint venture with Travelsanté (France) to offer personal medical records online and via the customer's mobile phone/PDA. As part of this package we also offer local country health information and drug equivalents. Travelsanté provides vital travel health information to many CAC-40 corporate clients, which includes companies such as Dow Chemical, Eurocopter and Ernst&Young (France). Our new joint product will be deployed in three international corporations within the coming weeks. We believe that we offer the most complete personal medical software package for international travelers available on the market.

  2. Upgrade completion of our Easy SmartCare software (v6.1) - This deadline was also achieved by the 1st of February 2012 to deploy our software for testing in one of Geneva's biggest radiology clinic (IIM clinic). We have integrated our system with the clinic's management system provided by Medspazio (WDS Technologies SA). Our software will automatically allow the clinic to communicate with their patients via the Internet/mobile phones/PDAs or via SMS messaging allowing the facility to confirm attendance, send out pre-visit questionnaires and preparation requirements, transfer patient's medical files, provide patient's with medications reminders and follow-up questionnaires resulting in end-to-end improved patient care. It is our intention to then deploy our new joint product to Medspazio's existing 80+ clinics/hospitals customers throughout Switzerland.

  3. United Arab Emirates National Diabetes Program - EasyMed is supplying our Disease Management software for their National Program. We have entered into an agreement with Modern Pharmaceutical Company (MPC) to be the technology provider for this pioneering National Program by the UAE health ministry. It is the aim of the project to improve the lives of over 300'000 citizens who suffer from diabetes.

  4. IBM certification - EasyMed has successfully being certified as an IBM partner on IBM Systems and IBM Database software. This insures that our software and technical management and processes meet some of the highest standards in the world, and that our software can easily be connected with other healthcare information system providers. We are presently working with IBM to complete their Healthcare Integration Framework (HIF) certification, IBM's highest product certification.

  5. Security System Upgrade - As our commitment to meeting the highest database security levels in the world, we have migrated over to new services at Grita data facility (France). We meet HIPAA, FDA, French and Swiss health ministry requirements for medical records protection and HL-7 for data exchange. The company believes that the safety of our clients' personal files is fundamental to the company's success. It is therefore our intention to always exceed regulatory standards and be on the leading edge of achieving the highest standards possible.

  6. Biosign Agreement - We have successfully signed an agreement with Biosign Technologies Inc. (TSX:BIO) to jointly distribute each others products and develop new products together that take advantage of each companies' specialty areas. Biosign produces patented medical devices for various health measurements. It is our intention to develop new joint products that attach these devices to patient's mobile phones through EasyMed technology allowing remote monitoring and tracking by the patients' caregivers.

  7. Sales and Marketing developments - EasyMed have recently strengthened our sales team in Europe and upgraded our sales literature. We believe that this area has been a weakness for the company in the past, and we will continue to focus on this area by further strengthening our sales teams and entering into joint ventures with companies that complement us in this area.

"I think that it is essential that major corporate milestones are brought to the attention of our valued shareholders. We hope that this synopsis will validate our message that we are going full throttle into commercialization. Our technology has been corroborated as a market leader and we expect our marketing to produce major results in the first two quarters of this year."

Andrew Ritchie

Chief Executive Officer

About EasyMed Services, Inc.

EasyMed Services, Inc. (CNSX:EZM)(OTCBB:EMYSF)(MUN:EY6) is a global medical information technology company delivering an end to end patient care solution through mobile phone/PDA and server technologies offering specialized services and applications for healthcare, insurance and pharmaceutical industries. We are committed to world-class customer service and the protection of our clients' information.

For more information, visit www.easymedservices.com.

This news release contains forward-looking statements, which relate to future events or future performance and reflect management's current expectations and assumptions. These forward-looking statements reflect management's current beliefs and are based on assumptions made by and information currently available to the Company. Investors are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected. These forward-looking statements are made as of the date hereof and, except as required under applicable securities legislation, the Company does not assume any obligation to update or revise them to reflect new events or circumstances.

The CNSX has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information